Gene Therapy Market Size, Revenue, Growth, Trend & Forecast Analysis, 2020 - 2027, By Indication, By Vector Type, By Country, & By Region

  • Report Id: HCDHR 2087
  • Published Date: August, 2020
  • No of Pages: 150
  • Format: Electronic (PDF)
  • Publisher: DataHorizzon Research
  • Category:

Gene Therapy Market Report Overview

Gene therapy market garnered a revenue of USD 2.6 billion in the year 2019 globally and has been foreseen to yield USD 8.2 billion by the year 2027 at a compound annual growth (CAGR) of 14.0% over the forecast period. The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.

Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.

Both the qualitative and quantitative aspects have been covered under the report. The gene therapy market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.

What to expect from the report?

  • Gene Therapy Total Available Market (TAM) Size
  • Gene Therapy Serviceable Available Market (SAM) Size
  • Business Implications of COVID-19 on the Overall Market
  • Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2019)
  • Market Size & Forecast (2016-2027) At Country & Regional Level, By Segments
  • Overview & Analysis of Key Players Operating in the Market

Key Highlights:

Parameters

Description

COVID-19

Impact of COVID-19 on overall business scenario

Gene Therapy Market Revenue 2020

Global market revenue in 2020 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic

Competitive Analysis

Company Market Share Analysis, 2019 (%)

Supply Chain Analysis

Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study

Data Source

Primary & Secondary Research, Internal Data Base & Company Annual Reports

Regions Included

North America, Europe, Asia Pacific, Latin America, & Middle East & Africa

Countries Included

U.S., Canada, U.K., Germany, France, Mexico, Brazil, China, India, Japan, South Korea, UAE, South Africa

Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Gene Therapy Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2019
Chapter 4. Gene Therapy Market: Indication Insights
4.1. Global Indication Historic Market Data & Future Forecasts, 2016-2027
4.2. Acute Lymphoblastic Leukemia (ALL)
4.2.1. Historic Market Data & Future Forecasts, 2016-2027
4.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.3. Inherited Retinal Disease
4.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4. Large B-cell Lymphoma
4.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.5. ADA-SCID
4.5.1. Historic Market Data & Future Forecasts, 2016-2027
4.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.6. Melanoma (Lesions)
4.6.1. Historic Market Data & Future Forecasts, 2016-2027
4.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.7. Beta-Thalassemia Major/SCD
4.7.1. Historic Market Data & Future Forecasts, 2016-2027
4.7.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.8. Head & Neck Squamous Cell Carcinoma
4.8.1. Historic Market Data & Future Forecasts, 2016-2027
4.8.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.9. Peripheral Arterial Disease
4.9.1. Historic Market Data & Future Forecasts, 2016-2027
4.9.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.10. Spinal Muscular Atrophy (SMA)
4.10.1. Historic Market Data & Future Forecasts, 2016-2027
4.10.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.11. Others
4.11.1. Historic Market Data & Future Forecasts, 2016-2027
4.11.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 5. Gene Therapy Market: Vector Type Insights
5.1. Global Vector Type Historic Market Data & Future Forecasts, 2016-2027
5.2. Lentivirus
5.2.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.3. AAV
5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.4. Retrovirus & Gammaretrovirus
5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.5. Modified Herpes Simplex Virus
5.5.1. Historic Market Data & Future Forecasts, 2016-2027
5.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.6. Adenovirus
5.6.1. Historic Market Data & Future Forecasts, 2016-2027
5.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.7. Non-viral Plasmid Vector
5.7.1. Historic Market Data & Future Forecasts, 2016-2027
5.7.2. Historic Market Data & Future Forecasts by Region, 2016-2027

Chapter 6. Gene Therapy Market: Regional Insights
6.1. Global Gene Therapy Market Data & Future Forecasts, By Region 2016-2027
6.2. North America
6.2.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.2.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.2.4. U.S.
6.2.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.2.4.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.2.5. Canada
6.2.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.2.5.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.3. Europe
6.3.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.3.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.3.4. U.K.
6.3.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.3.4.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.3.5. Germany
6.3.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.3.5.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.3.6. France
6.3.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.6.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.3.6.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.4. Asia Pacific
6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.4.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.4.4. China
6.4.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.4.4.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.4.5. India
6.4.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.4.5.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.4.6. Japan
6.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.6.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.4.6.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.4.7. South Korea
6.4.7.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.7.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.4.7.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.5. Latin America
6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.5.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.5.4. Brazil
6.5.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.5.4.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.5.5. Mexico
6.5.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.5.5.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.6. Middle East & Africa
6.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.6.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.6.4. UAE
6.6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.6.4.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
6.6.5. South Africa
6.6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.6.5.3. Historic Market Data & Future Forecasts, By Vector Type, 2016-2027
Chapter 7. Company Profiles
7.1. Celgene Corporation
7.1.1. Company Description
7.1.2. Financial Highlights
7.1.3. Product Portfolio
7.1.4. Strategic Initiatives
7.2. Human Stem Cell Institute
7.2.1. Company Description
7.2.2. Financial Highlights
7.2.3. Product Portfolio
7.2.4. Strategic Initiatives
7.3. UniQure NV
7.3.1. Company Description
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. Strategic Initiatives
7.4. Bristol Myer’s Squibb
7.4.1. Company Description
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. Strategic Initiatives
7.5. Chiesi Farmaceutici S.p.A
7.5.1. Company Description
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. Strategic Initiatives
7.6. Dimension Therapeutics
7.6.1. Company Description
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. Strategic Initiatives
7.7. Voyager Therapeutics
7.7.1. Company Description
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. Strategic Initiatives
7.8. Shire Plc
7.8.1. Company Description
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. Strategic Initiatives
7.9. Sangamo Biosciences
7.9.1. Company Description
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. Strategic Initiatives
7.10. GlaxoSmithKline
7.10.1. Company Description
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. Strategic Initiatives
List of Tables
Table 1 Gene Therapy Market Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 2 Gene Therapy Market Data & Future Forecasts, By Region, 2016-2027 (USD Billion)
Table 3 Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 4 Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 5 Acute Lymphoblastic Leukemia (ALL) Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 6 Inherited Retinal Disease Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 7 Large B-cell Lymphoma Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 8 ADA-SCID Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 9 Melanoma (Lesions) Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 10 Beta-Thalassemia Major/SCD Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 11 Head & Neck Squamous Cell Carcinoma Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 12 Peripheral Arterial DiseaseMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 13 Spinal Muscular Atrophy (SMA) Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 14 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 14 Lentivirus Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 16 AAV Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 17 Retrovirus & Gammaretrovirus Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 18 Modified Herpes Simplex Virus Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 19 Adenovirus Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 20 Non-viral Plasmid Vector Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 21 North America Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 22 North America Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 23 North America Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 24 U.S. Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 25 U.S. Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 26 U.S. Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 27 Canada Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 28 Canada Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 29 Canada Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 30 Europe Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 31 Europe Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 32 Europe Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 33 U.K. Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 34 U.K Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 35 U.K Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 36 Germany Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 37 Germany Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 38 Germany Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 39 France Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 40 France Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 41 France Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 42 Asia Pacific Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 43 Asia Pacific Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 44 Asia Pacific Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 45 China Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 46 China Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 47 China Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 48 India Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 49 India Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 50 India Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 51 Japan Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 52 Japan Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 53 Japan Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 54 South Korea Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 55 South Korea Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 56 South Korea Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 57 Latin America Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 58 Latin America Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 59 Latin America Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 60 Brazil Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 61 Brazil Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 61 Brazil Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 63 Mexico Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 64 Mexico Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 65 Mexico Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 66 Middle East & Africa Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 67 Middle East & Africa Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 68 Middle East & Africa Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 69 UAE Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 70 UAE Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 71 UAE Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
Table 72 South Africa Gene Therapy Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 73 South Africa Gene Therapy Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 74 South Africa Gene Therapy Market Data & Future Forecasts, By Vector Type, 2016-2027 (USD Billion)
List of Figures
Fig.1 Data Analysis Model
Fig.2 Gene Therapy Market, by 2016-2027 (USD Billion)
Fig.3 Gene Therapy Market Segmentation
Fig.4 Supply chain analysis
Fig.5 Gene Therapy Market Driver Anlaysis
Fig.6 Gene Therapy Market Restraint Analysis
Fig.7 Gene Therapy Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Gene Therapy Market
Fig.10 Company Market Share Analysis, 2019

Gene Therapy Market Segmentation:

Gene Therapy Market, By Indication (2016-2027)

  • Acute Lymphoblastic Leukemia (ALL)
  • Inherited Retinal Disease
  • Large B-cell Lymphoma
  • ADA-SCID
  • Melanoma (Lesions)
  • Beta-Thalassemia Major/SCD
  • Head & Neck Squamous Cell Carcinoma
  • Peripheral Arterial Disease
  • Spinal Muscular Atrophy (SMA)
  • Others

 

Gene Therapy Market, By Vector Type (2016-2027)

  • Lentivirus
  • AAV
  • Retrovirus & Gammaretrovirus
  • Modified Herpes Simplex Virus
  • Adenovirus
  • Non-viral Plasmid Vector

Gene Therapy Market, By Region (2016-2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • South Africa

Major Players Operating in the Gene Therapy Market:

  • Celgene Corporation
  • Human Stem Cell Institute
  • UniQure NV
  • Bristol Myer’s Squibb
  • Chiesi Farmaceutici S.p.A
  • Dimension Therapeutics
  • Voyager Therapeutics
  • Shire Plc
  • Sangamo Biosciences
  • GlaxoSmithKline

Choose License Type

Single user
$3,960
Multi User
$4,950
Enterprise User
$5,940
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.